<DOC>
	<DOC>NCT00496184</DOC>
	<brief_summary>To evaluate the use of topical application of Nifedipine cream for the treatment of Provoked localized Vulvodynia (vestibulitis, vestibulodynia).</brief_summary>
	<brief_title>Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis</brief_title>
	<detailed_description>30 women aged 18-45 diagnosed with Provoked localized Vulvodynia will be included. 10 women will use topical Nifedipine cream 0.2% 4 times a day for 6 weeks (except for menstrual period). 10 other women will use topical Nifedipine cream 0.4% 4 times a day for 6 weeks (except for menstrual period). 10 women will be a control group and will use a placebo cream. The study will be randomized and double blind. Participants will be examined before starting the treatment, at the end of the treatment and 3 months after completion the treatment. A special detailed questionnaire has been prepared in three languages and will be used to compare dyspareunia and associate variables between the groups. The Q-tip tests will be performed and findings will be drawn in each examination. Differences between the groups will be examined, and uni- and multi-variate analysis will be performed.</detailed_description>
	<mesh_term>Vulvodynia</mesh_term>
	<mesh_term>Vulvar Vestibulitis</mesh_term>
	<mesh_term>Vulvar Diseases</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>1. Women diagnosed with vestibulitis according to Friedrich's criteria: Severe pain with vestibular touch or attempted vaginal entry. A positive Qtip test: pain produced by touching the vestibule with a cotton tipped applicator. Physical findings limited to varying degree of vestibular erythema. 2. Nonpregnant women aged 1845. 3. Women use effective contraception and are not interested in becoming pregnant during the study period. 4. No known Nifedipine allergy. 5. No medical diseases. 1. Women who have undergone vestibulectomy. 2. Active vaginal or pelvic infection. 3. A medical disease uch as Diabetes, immune suppression.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Nifedipine treatment</keyword>
	<keyword>Vestibulitis</keyword>
	<keyword>Placebo</keyword>
</DOC>